Why, how, and how far should microbiological contamination in a coastal zone be mitigated? An application of the systems approach to the Thau lagoon (France).

This paper describes the building of an integrated simulation tool based on a systems approach, and its contribution to local political discussion of the mitigation of microbiological contamination of the water in a coastal area. Local management schemes view water quality as a high-priority environmental objective. In practice, how far this objective is achieved depends on trade-offs between the costs of improved water treatment facilities and the acceptable impacts of water contamination. An in-the-field experiment in collaboration with local managers was carried out in the Thau lagoon on the French Mediterranean coast during the SPICOSA (Science and Policy Integration for Coastal System Assessment) project, from 2007 through 2011. It consisted of building a modeling platform and an integrated assessment framework for simulating exploratory scenarios. The modeling platform combines a dynamic contamination model, which represents the sources of microbiological contamination, wastewater treatment facilities, and physical mechanisms of lagoon contamination, with a prospective economic model, which estimates the patterns of development of economic activities in the area through a holistic approach. Exploratory scenarios are used to assess the risk of water contamination and the efficiency of management measures, under various assumptions about the evolution of the system. The contamination simulations suggest that the work currently planned by local authorities will be inadequate for preventing increased water pollution, and that additional but fairly inexpensive management measures for maintaining the current level of water quality should be considered. The integrated assessment framework estimates the ecological and socio-economic impacts of the various pollution mitigation policies in the broader context of possible local development patterns. The results illustrate how the systems approach may aid in the design of an applicable water policy based on operational objectives and feasible technical options.

Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats.

BACKGROUND: Glioblastomas are the third most common cause of cancer death in patients between 15 and 35 years old. Literature suggests that PDT could represent a promising treatment, providing that sensitizers could accumulate within the cancer tissues despite the blood-brain barrier. METHODS: Distribution and PDT effect of SIM01, a promising photosensitizer, have been evaluated on orthotopic C6 tumor model in rats by comparison with HPD and m-THPC. Pharmacokinetics had been analyzed with fluorescence and ROS. Photodynamic treatment was done using a 630-nm light with an energy density of 100 J cm(-2) for HPD and a 652-nm light with an energy density of 20 J cm(-2) for m-THPC and SIM01. RESULTS: The correlation between fluorescence and ROS dosimetry was found to be excellent. An optimal concentration was found after 12 hours for SIM01 (4 mg/kg), 24 hours for HPD (10 mg/kg), and 48 hours for m-THPC (4 mg/kg). The best normal tissue/cancer ratio of concentration had been found after 12 hours for SIM01 and 48 hours for HPD and m-THPC. Pathological examinations after PDT showed that the criteria for histology of glioblastic origin were absent in SIM01-treated rats 12 hours after injection but were present in 50% of rats treated 24 hours after injection and in all after a 48-hour delay. Mean survival of rats treated 12 or 24 hours after SIM01 injection was significantly improved compared with controls, HPD-, or m-THPC-treated groups. Survival of rats treated 12 or 24 hours after SIM01 injection reached 20 days but decreased for longer delays. On the contrary, survival reached 18 days at the maximum for rats treated 48 hours after m-THPC or HPD injection. CONCLUSIONS: Our results confirm that PDT is a promising treatment for glioblastomas. SIM01 efficacy is as efficient as m-THPC but with much more favorable pharmacokinetics.